ÇãÇ÷¼º ½ÉÁúȯ¿¡¼ÀÇ ½É½Çºó¸Æ°ú »ðÀÔÇü Á¦¼¼µ¿±â ½Ã¼ú
A case of ischemic non-sustained ventricular tachycardia treated by ICD for primary prevention of sudden cardiac death
International Journal of Arrhythmia 2010³â 11±Ç 2È£ p.43 ~ p.46
¿Â¿µ±Ù(On Young-Keun) - ¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
Abstract
It has been reported that 75% of the patients dying of sudden cardiac death (SCD) have coronary heart disease. The rhythm most often recorded at the time of sudden cardiac arrest is ventricular fibrillation. No antiarrhythmic agent has clearly been demonstrated to reduce total and SCD mortality in patients at risk for SCD. Implantable cardioverter-defibrillator (ICD) therapy, compared with conventional or traditional antiarrhythmic drug therapy, has been associated with mortality reductions from 23% to 55%, depending on the risk group participating in the trial. The improvement in survival with ICD therapy is almost exclusively due to a reduction in SCD. We reported here on a syncope patient with a history of previous myocardial infarction. The cardiac electrophysiology study revealed sustained ventricular tachycardia and fibrillation presented with loss of consciousness.
Å°¿öµå
sudden cardiac death, coronary heart disease, implantable cardioverter-defibrillator
KMID :
1011920100110020043
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)
Implantable cardioverter-defibrillator (ICD) therapy, compared with conventional or traditional antiarrhythmic drug therapy, has been associated with mortality reductions from 23% to 55%, depending on the risk group participating in the trial.